Synergistic effect of erythromycin on polymorphonuclear cell antibacterial activity against erythromycin-resistant phenotypes of Streptococcus pyogenes

International Journal of Antimicrobial Agents

Volumn 36, Issue 4, 2010, Pages 319-323

  Banche, Giuliana ^a   Tullio, Vivian ^b   Allizond, Valeria ^a   Mandras, Narcisa ^a   Roana, Janira ^a   Scalas, Daniela ^a   El Fassi, Fadwa ^a   D'Antico, Sergio ^b   Cuffini, Anna Maria ^a   Carlone, Nicola ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b AOU San Giovanni Battista   (Italy)

Author keywords

Erythromycin; Phagocytic killing; Phagocytosis; Polymorphonuclear cells; Streptococcus pyogenes

Indexed keywords

ERYTHROMYCIN; MACROLIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; NEUTROPHILS; PHAGOCYTOSIS; PHENOTYPE; SERUM BACTERICIDAL TEST; STREPTOCOCCUS PYOGENES;

EID: 77955917498     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.06.041     Document Type: Article

References (36)

1. Bae S.Y., Kim J.S., Kwon J.A., Yoon S.Y., Lim C.S., Lee K.N., et al. Phenotypes and genotypes of macrolide-resistant Streptococcus pyogenes isolated in Seoul, Korea. J Med Microbiol 2007, 56:229-235.
2. Gracia M., Díaz C., Coronel P., Gimeno M., García-Rodas R., Rodríguez-Cerrato V., et al. Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program. Diagn Microbiol Infect Dis 2009, 64:52-56.
3. Hart A.M., Patti A., Noggle B., Haller-Stevenson E., Hines L.B. Acute respiratory infections and antimicrobial resistance. Am J Nurs 2008, 108:56-65.
4. Malbruny B., Nagai K., Coquemont M., Bozdogan B., Andrasevic A.T., Hupkova H., et al. Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. J Antimicrob Chemother 2002, 49:935-939.
5. Shibl A.M. Patterns of macrolide resistance determinants among S. pyogenes and S. pneumoniae isolates in Saudi Arabia. J Int Med Res 2005, 33:349-355.
6. Varaldo P.E., Montanari M.P., Giovanetti E. Genetic elements responsible for erythromycin resistance in streptococci. Antimicrob Agents Chemother 2009, 53:343-353.
7. Banche G., Roana J., Allizond V., Andreotti S., Malabaila A., Li Vigni N., et al. In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. Lett Appl Microbiol 2008, 47:309-314.
8. Montagnani F., Stolzuoli L., Croci L., Rizzuti C., Arena F., Zanchi A., et al. Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region. Infection 2009, 37:353-357.
9. Descheemaeker P., Chapelle S., Lammens C., Hauchecorne M., Wijdooghe M., Vandamme P., et al. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. J Antimicrob Chemother 2000, 45:167-173.
10. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002, 34:482-492.
11. Amsden G.W. Pneumococcal macrolide resistance-myth or reality?. J Antimicrob Chemother 1999, 44:1-6.
12. Cuffini A.M., Tullio V., Mandras N., Roana J., Scalas D., Banche G., et al. Clarithromycin mediated the expression of polymorphonuclear granulocyte response against Streptococcus pneumoniae strains with different patterns of susceptibility and resistance to penicillin and clarithromycin. Int J Tissue React 2002, 24:37-44.
13. Rondini G., Cocuzza C.E., Cianflone M., Lanzafame A., Santini L., Mattina R. Bacteriological and clinical efficacy of various antibiotics used in the treatment of streptococcal pharyngitis in Italy. An epidemiological study. Int J Antimicrob Agents 2001, 18:9-17.
14. Cuffini A.M., Tullio V., Mandras N., Roana J., Banche G., Carlone N.A. The leading role of antimicrobial agents in modulating the binomial host-microorganism. Curr Med Chem Anti Infect Agents 2004, 3:1-13.
15. Kobayashi S.D., Voyich J.M., DeLeo F.R. Regulation of the neutrophil-mediated inflammatory response to infection. Microbes Infect 2003, 5:1337-1344.
16. Voyich J.M., Sturdevant D.E., Braughton K.R., Kobayashi S.D., Lei B., Virtaneva K., et al. Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A 2003, 100:1996-2001.
17. Labro M.T. Interference of antibacterial agents with phagocyte functions: immunomodulation or 'immuno-fairy tales'?. Clin Microbiol Rev 2000, 13:615-650.
18. Martin J.R., Johnson P., Miller M.F. Uptake, accumulation, and egress of erythromycin by tissue culture cells of human origin. Antimicrob Agents Chemother 1985, 27:314-319.
19. Miller M.F., Martin J.R., Johnson P., Ulrich J.T., Rdzok E.J., Billing P. Erythromycin uptake and accumulation by human polymorphonuclear leukocytes and efficacy of erythromycin in killing ingested Legionella pneumophila. J Infect Dis 1984, 149:714-718.
20. Prokesch R.C., Hand W.L. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1982, 21:373-380.
21. Cuffini A.M., Carlone N.A., Tullio V., Borsotto M. Comparative effects of roxithromycin and erythromycin on cellular immune functions in vitro. 3. Killing of intracellular Staphylococcus aureus by human macrophages. Microbios 1989, 58:27-33.
22. Cuffini A.M., Tullio V., Cimino F., Carlone N.A. Comparative effects of roxithromycin and erythromycin on cellular immune functions in vitro. 1. Uptake of 3H-macrolides by human macrophages. Microbios 1989, 57:167-178.
23. Banche G., Allizond V., Giacchino F., Mandras N., Roana J., Bonello F., et al. Effect of dialysis membrane biocompatibility on polymorphonuclear granulocyte activity in dialysis patients. Nephrol Dial Transplant 2006, 21:3532-3538.
24. Cuffini A.M., Tullio V., Banche G., Allizond V., Mandras N., Roana J., et al. The erythromycin-resistance in S. pyogenes does not limit the human polymorphonuclear cell antimicrobial activity. Int J Immunopathol Pharmacol 2009, 22:239-242.
25. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008.
26. Giovanetti E., Montanari M.P., Mingoia M., Varaldo P.E. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob Agents Chemother 1999, 43:1935-1940.
27. Giovanetti E., Brenciani A., Burioni R., Varaldo P.E. A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes. Antimicrob Agents Chemother 2002, 46:3750-3755.
28. Hyder S.L., Streitfeld M.M. Inducible and constitutive resistance to macrolide antibiotics and lincomycin in clinically isolated strains of Streptococcus pyogenes. Antimicrob Agents Chemother 1973, 4:327-331.
29. Cuffini A.M., Tullio V., Bonino A., Allocco A., Palarchio A.I., Carlone N.A. Entry of sanfetrinem into human polymorphonuclear granulocytes and its cell-associated activity against intracellular, penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 1998, 42:1745-1750.
30. Cuffini A.M., Tullio V., Giacchino F., Mandras N., Scalas D., Belardi P., et al. Impact of co-amoxiclav on polymorphonuclear granulocytes from chronic hemodialysis patients. Am J Kidney Dis 2001, 37:1253-1259.
31. Tullio V., Cuffini A.M., Banche G., Mandras N., Allizond V., Roana J., et al. Role of fosfomycin tromethamine in modulating non-specific defence mechanisms in chronic uremic patients towards ESBL-producing Escherichia coli. Int J Immunopathol Pharmacol 2008, 21:153-160.
32. Allen L.A. Mechanisms of pathogenesis: evasion of killing by polymorphonuclear leukocytes. Microbes Infect 2003, 5:1329-1335.
33. Voyich J.M., Braughton K.R., Sturdevant D.E., Vuong C., Kobayashi S.D., Porcella S.F., et al. Engagement of the pathogen survival response used by group A Streptococcus to avert destruction by innate host defense. J Immunol 2004, 173:1194-1201.
34. Voyich J.M., Musser J.M., DeLeo F.R. Streptococcus pyogenes and human neutrophils: a paradigm for evasion of innate host defense by bacterial pathogens. Microbes Infect 2004, 6:1117-1123.
35. Staali L., Bauer S., Mörgelin M., Björck L., Tapper H. Streptococcus pyogenes bacteria modulate membrane traffic in human neutrophils and selectively inhibit azurophilic granule fusion with phagosomes. Cell Microbiol 2006, 8:690-703.
36. Kobayashi S.D., Braughton K.R., Whitney A.R., Voyich J.M., Schwan T.G., Musser J.M., et al. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci U S A 2003, 100:10948-10953.